Martina Ondrušová, Dalibor Ondruš
Introduction: Worldwide estimates rank Slovakia among countries with a high incidence of prostate cancer. Predictions of incidence
for the near future indicate prostate cancer as the most frequent among all malignant tumours in males in Slovakia.
Aim: The aim of the submitted paper is to analyse the prostate cancer incidence and mortality in Slovakia and to compare
the trends in selected countries and regions of the world. To predict the development of selected indicators of descriptive
epidemiology of prostate cancer in Slovakia and to provide relevant and updated data for further analyses and
to evaluate the impacts of interventions.
Material and methods: Analyses of national data take into account the period 1968-2010. The trends in prostate cancer
incidence and mortality have been extracted using joinpoint regression model and are presented with 95 % Confidence
Intervals (CI) and p-value with null hypothesis being constant within the time. Predictions of incidence and prevalence
were calculated by the year 2014 and 2015, respectively.
Results: A significant rise in the disease incidence is observed in Slovakia (from 14.5/100 000 in 1980 to 54.9/100 000 in
2010), in recent years as much as 6.7% annually. The mortality values are growing at a slower rate, from 9.4/100 000 up
to 13.9/100 000 recorded in 2010, while there were observed stable or mild decreasing trends in the national mortality
data of prostate cancer. These facts make prostate cancer the most common malignant tumour in males.
Conclusion: In Slovakia, no peak is being registered with a subsequent drop in the values of prostate cancer incidence
as it in several countries performing screening of this disease. The development of mortality reveals a favourable trend
in current national data.